Data / Form D filings / Navigator Medicines, Inc.
Navigator Medicines, Inc.: Form D filings
Navigator Medicines, Inc., a biotechnology company in San Mateo, CA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on September 25, 2026, reports $10 million sold of a $40 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1825 S GRANT ST. SUITE 200, San Mateo, CA, 94402
- Phone
- (650) 240-8794
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2035715
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | New notice | $40,000,000 | $10,000,000 | $30,000,000 | 3 | Sep 18, 2026 | sec.gov |
| Sep 5, 2024 | New notice | $99,999,993 | $49,999,998 | $49,999,995 | 4 | Aug 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TAUSIF BUTT | Executive Officer, Director, Promoter | |
| STEPHEN BASIL THOMAS | Executive Officer, Director, Promoter | |
| SCOTT FORREST | Executive Officer | |
| WOUTER JOUSTRA | Director | |
| KHUREM FAROOQ | Director | |
| MATHIAS VINTHER | Director | |
| KRISTIE GREBE | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Navigator Medicines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.